Patient P-03319
Therapy response
Unstable
Tolerance
Favorable
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
17%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S07
- Day 26 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 26.
Primary contributors, last 14 days
- Nutritional resilience+14
- GI instability-13
- Inflammatory activity-4
- Toxicity+3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log4.5/10
improving · +0.2 vs previous 14 d
Stress level
Daily log4.5/10
improving · -0.5 vs previous 14 d
Pessimism score
Daily log5.2/10
stable · -0.1 vs previous 14 d
Sleep quality
Wearable41.5/100
improving · +6.7 vs previous 14 d
Libido
Daily log3.7/10
improving · +0.3 vs previous 14 d
HRV
Wearable49.1 ms
improving · +1.9 vs previous 14 d
Toxicity
Blood21.2/100
worsening · +3.2 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →Heading towards restoration · 67 from the failing basin, 52 from restoration.
Good elements to keep
- Butyrate producers intacthidden · steering +7.5
- Protein (supports)perturbation · steering +7.3
- Proteinsupporter · GI -3.8 next day
Main detractors to watch
- Rapid metabolizerhidden · steering -8
- Antibiotic courseperturbation · steering -4.7
- Low-HRV stretchperturbation · steering -2.7
- Alcohol on dosing daysperturbation · steering -1.8
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.8supporter · 95%
- Lactose+0.7no signal · 17%
- Dietary fat load+0.4no signal · 15%
- Caffeine+0.4no signal · 15%
- Histamine load+0.1no signal · 15%
- Alcohol0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Autonomic recovery ↑20
- WearableShort sleep window
- Mucosal barrier integrity ↓10
- WearableSleep 6.0 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Rapid metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 4 · butyrate capacity 63/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 46 ms
- Sleep
- 6.4 h
- Steps
- 9,620
- Resting HR
- 70 bpm
Daily log: GI score 17, nutritional resilience 71, adherence 82.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.